百济神州参投,可编程 mRNA实现 IL-12瘤内定向激活,开启“mRNA 2.0”

动脉网
May 01, 2025

Strand Therapeutics展示了一种可编程mRNA疗法STX-003,能精准调控IL-12在肿瘤组织的表达,提高耐受性并维持抗肿瘤疗效,其核心优势在于自复制mRNA与遗传电路的结合,为肿瘤治疗提供创新策略。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10